close

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.450 -0.010 (-0.68%)
Streaming Delayed Price Updated: 9:42 AM EDT, Oct 31, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 6,044
Open 1.460
Bid (Size) 1.430 (7)
Ask (Size) 1.480 (7)
Prev. Close 1.460
Today's Range 1.440 - 1.460
52wk Range 1.415 - 4.200
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
-55.9%
-55.9%
1 Month
-10.5%
-10.5%
3 Month
-8.2%
-8.2%
6 Month
-35.3%
-35.3%
1 Year
-47.6%
-47.6%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.450
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 10/31/25 09:42 AM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 45.03M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 45M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today